Tissue Regenix Group plc (LON:TRX – Get Free Report)’s share price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 58.87 ($0.73) and traded as low as GBX 58 ($0.72). Tissue Regenix Group shares last traded at GBX 58.02 ($0.72), with a volume of 61,040 shares.
Tissue Regenix Group Stock Performance
The business’s fifty day moving average price is GBX 57.99 and its two-hundred day moving average price is GBX 58.87. The company has a debt-to-equity ratio of 35.69, a quick ratio of 2.36 and a current ratio of 3.74. The stock has a market capitalization of £41.33 million, a P/E ratio of -5,802.00 and a beta of 1.61.
About Tissue Regenix Group
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Recommended Stories
- Five stocks we like better than Tissue Regenix Group
- Overbought Stocks Explained: Should You Trade Them?
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- The 3 Best Blue-Chip Stocks to Buy Now
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
